Individuals with asymptomatic AD (Asym AD) included in this analysis exhibited minimal cognitive impairment with moderate to high amyloid plaque frequency but with low to no cortical tau pathology (Table S4) [37]. The gene discussed is MAPT; the disease is Alzheimer disease.